News

How to overcome potential misconceptions around the need for cervical screening among women how have had HPV vaccine (jab) ...
China’s National Medical Products Administration has cleared Cecolin 9, the country’s first domestically developed ...
CHINA’s global Human Papilloma Virus (HPV) vaccines manufacturer, Xiamen Innovax Biotech Co., Ltd welcomed Pacific Islands ...
The Health Department Sindh, convened a landmark Provincial Steering Committee (PSC) meeting held here on Tuesday to finalize plans for the introduction of the Human Papillomavirus (HPV) vaccine, a ...
The FDA has approved Teal Health's at-home test for HPV detection, which may help expand access to cervical cancer screening for more women.
In the ESCUDDO trial, which involved more than 20,000 girls ages 12 to 16, one dose of both the bivalent Cervarix and 9-valent Gardasil 9 HPV vaccines provided similar protection to two doses ...
A medical staff member injects domestically produced bivalent HPV vaccine to a girl in Lianyungang, Jiangsu province, in May 2023. ZHU HUANAN/FOR CHINA DAILY As the domestic market approaches a ...
Currently, five HPV vaccines have been approved for use in China — three bivalent, one quadrivalent, and one nine-valent. Among these, domestic manufacturers account for two bivalent HPV ...
“The nonavalent HPV vaccine offers broader coverage than the bivalent and quadrivalent vaccines, protecting against nine HPV types,” PIDSOG emphasized in its position statement ...
CSPC Pharmaceutical Group has received approval from China’s National Medical Products Administration to conduct clinical trials for its innovative bivalent HPV mRNA vaccine, SYS6026.